21 May 2021 - A biosimilar brand of bevacizumab (Mvasi) will be listed on the PBS on 1 June 2021. Information ...
18 May 2021 - Biosimilars Canada today congratulated the Government of Quebec and Minister of Health and Social Services Christian ...
18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...
17 May 2021 - New Sandoz biosimilar launch can potentially lower healthcare costs, especially for Canadian hospitals, as 75% of the ...
6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...
28 April 2021 - Additional provincial coverage expected to follow. ...
21 April 2021 - Biosimilars Canada today congratulated the Government of New Brunswick for implementing a biosimilar "switching" or transitioning ...
29 March 2021 - Samsung Bioepis’ adalimumab is now available in three markets: Europe, Canada and Australia. ...
9 March 2021 - PHARMAC invites proposals for the supply of adalimumab in New Zealand. ...
18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...
15 February 2021 - While apparently non‐inferior to originator biologics, other factors need to be considered before switching ...
5 November 2020 - Following the launch of its Biosimilars Initiative in December 2019, Alberta, Canada, has succeeded in switching 16% ...
29 September 2020 - Investigators have concluded that fully realizing the cost-saving potential of biosimilars could “release enormous resources” for ...
11 September 2020 - A biosimilar brand of pegfilgrastim (Pelgraz) was listed on the PBS on 1 August 2020. ...
26 August 2020 - The launch marks the first European market entry for Nepexto. ...